Signum Biosciences

Signum Biosciences Awarded Two Additional NIH Grants for Development of Topical Therapeutics

Proprietary skincare technology platform reaches market

PRINCETON, New Jersey, September 20, 2010 - Signum Biosciences, Inc.

Older News

PRINCETON, New Jersey, July 13, 2010 - Signum Biosciences announced that its partner, Rohto Pharmaceutical Co., Ltd., has launched AFC Medirepair(R) with Signum's compound Arazine(TM) (n-acetyl-s-farnsylcysteine or AFC) in Japan.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy